Advertisement
Screener

Myomo, Inc. (MYO) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

Myomo, Inc. Research and Development Expense

Myomo, Inc. (MYO) reported Research and Development Expense of $1.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05

  • Myomo, Inc. research and development expense for the quarter ending 2026-06-30 was $1.72M, a 14.03% decline year-over-year.
  • Myomo, Inc. research and development expense for the quarter ending 2026-03-31 was $1.62M, a 9.32% decline year-over-year.
  • Myomo, Inc. research and development expense for the quarter ending 2025-12-31 was $1.62M, a 4.18% increase year-over-year.
  • Myomo, Inc. research and development expense for the quarter ending 2025-09-30 was $1.53M, a 22.32% increase year-over-year.
  • Myomo, Inc. research and development expense for fiscal 2025 was $6.94M, a 45.51% increase from fiscal 2024.
  • Myomo, Inc. research and development expense for fiscal 2024 was $4.77M, a 81.00% increase from fiscal 2023.
  • Myomo, Inc. research and development expense for fiscal 2023 was $2.64M, a 6.20% increase from fiscal 2022.
  • Myomo, Inc. research and development expense for fiscal 2022 was $2.48M, a 2.93% decline from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$1.72M
10-Q · filed 2026-08-05
$3.34M
10-Q · filed 2026-08-05
$4.97M
derived: sum of 3 quarters · filed 2026-08-05
$6.50M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$1.62M
10-Q · filed 2026-05-07
$3.25M
derived: sum of 2 quarters · filed 2026-05-07
$4.78M
derived: sum of 3 quarters · filed 2026-05-07
$6.78M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$3.15M
derived: sum of 2 quarters · filed 2026-03-09
$5.15M
derived: sum of 3 quarters · filed 2026-08-05
$6.94M
10-K · filed 2026-03-09
2025-09-30$1.53M
10-Q · filed 2025-11-10
$3.53M
derived: sum of 2 quarters · filed 2026-08-05
$5.32M
10-Q · filed 2025-11-10
$6.88M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$2.00M
10-Q · filed 2026-08-05
$3.79M
10-Q · filed 2026-08-05
$5.35M
derived: sum of 3 quarters · filed 2026-08-05
$6.60M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.79M
10-Q · filed 2026-05-07
$3.35M
derived: sum of 2 quarters · filed 2026-05-07
$4.60M
derived: sum of 3 quarters · filed 2026-05-07
$5.61M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$2.81M
derived: sum of 2 quarters · filed 2026-03-09
$3.82M
derived: sum of 3 quarters · filed 2026-03-09
$4.77M
10-K · filed 2026-03-09
2024-09-30$1.25M
10-Q · filed 2025-11-10
$2.26M
derived: sum of 2 quarters · filed 2025-11-10
$3.21M
10-Q · filed 2025-11-10
$4.09M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$1.01M
10-Q · filed 2025-08-11
$1.96M
10-Q · filed 2025-08-11
$2.84M
derived: sum of 3 quarters · filed 2025-08-11
$3.56M
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$956.22K
10-Q · filed 2025-05-07
$1.83M
derived: sum of 2 quarters · filed 2025-05-07
$2.55M
derived: sum of 3 quarters · filed 2025-05-07
$3.12M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31$878.01K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$1.60M
derived: sum of 2 quarters · filed 2025-03-10
$2.16M
derived: sum of 3 quarters · filed 2025-03-10
$2.64M
10-K · filed 2025-03-10
2023-09-30$717.26K
10-Q · filed 2024-11-06
$1.28M
derived: sum of 2 quarters · filed 2024-11-06
$1.76M
10-Q · filed 2024-11-06
$1.76M
10-Q · filed 2023-11-07
$2.26M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30$564.24K
10-Q · filed 2024-08-06
$1.04M
10-Q · filed 2024-08-06
$1.54M
derived: sum of 3 quarters · filed 2024-08-06
$2.23M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31$476.99K
10-Q · filed 2024-05-08
$976.66K
derived: sum of 2 quarters · filed 2024-05-08
$1.67M
derived: sum of 3 quarters · filed 2024-05-08
$2.30M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$499.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$1.19M
derived: sum of 2 quarters · filed 2024-03-08
$1.82M
derived: sum of 3 quarters · filed 2024-03-08
$2.48M
10-K · filed 2024-03-08
2022-09-30$690.41K
10-Q · filed 2023-11-07
$1.32M
derived: sum of 2 quarters · filed 2023-11-07
$1.98M
10-Q · filed 2023-11-07
$2.77M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$632.87K
10-Q · filed 2023-08-09
$1.29M
10-Q · filed 2023-08-09
$2.08M
derived: sum of 3 quarters · filed 2023-08-09
$2.72M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$659.54K
10-Q · filed 2023-05-10
$1.45M
derived: sum of 2 quarters · filed 2023-05-10
$2.09M
derived: sum of 3 quarters · filed 2023-05-10
$2.69M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$787.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
$1.43M
derived: sum of 2 quarters · filed 2023-03-13
$2.03M
derived: sum of 3 quarters · filed 2023-03-13
$2.56M
10-K · filed 2023-03-13
2021-09-30$641.23K
10-Q · filed 2022-11-10
$1.24M
derived: sum of 2 quarters · filed 2022-11-10
$1.77M
10-Q · filed 2022-11-10
$2.19M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$600.12K
10-Q · filed 2022-08-03
$1.13M
10-Q · filed 2022-08-03
$1.54M
derived: sum of 3 quarters · filed 2022-08-03
$1.89M
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31$525.97K
10-Q · filed 2022-05-11
$944.73K
derived: sum of 2 quarters · filed 2022-05-11
$1.29M
derived: sum of 3 quarters · filed 2022-05-11
$1.69M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$418.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$764.42K
derived: sum of 2 quarters · filed 2022-03-11
$1.16M
derived: sum of 3 quarters · filed 2022-03-11
$1.67M
10-K · filed 2022-03-11
2020-09-30$345.67K
10-Q · filed 2021-11-10
$743.48K
derived: sum of 2 quarters · filed 2021-11-10
$1.25M
10-Q · filed 2021-11-10
$1.69M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$397.81K
10-Q · filed 2021-08-09
$904.76K
10-Q · filed 2021-08-09
$1.35M
derived: sum of 3 quarters · filed 2021-08-09
$1.78M
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31$506.95K
10-Q · filed 2021-05-05
$949.48K
derived: sum of 2 quarters · filed 2021-05-05
$1.38M
derived: sum of 3 quarters · filed 2021-05-05
$1.81M
derived: sum of 4 quarters · filed 2021-05-05
2019-12-31$442.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$875.59K
derived: sum of 2 quarters · filed 2021-03-10
$1.30M
derived: sum of 3 quarters · filed 2021-03-10
$1.75M
10-K · filed 2021-03-10
$2.16M
10-K · filed 2020-03-13
2019-09-30$433.06K
10-Q · filed 2020-11-10
$544.68K
10-Q · filed 2019-11-12
$860.64K
derived: sum of 2 quarters · filed 2020-11-10
$1.31M
10-Q · filed 2020-11-10
$1.62M
10-Q · filed 2019-11-12
$1.84M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$427.57K
10-Q · filed 2020-08-10
$535.90K
10-Q · filed 2019-08-08
$873.92K
10-Q · filed 2020-08-10
$1.07M
10-Q · filed 2019-08-08
$1.40M
derived: sum of 3 quarters · filed 2020-08-10
$1.85M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$446.35K
10-Q · filed 2020-05-14
$535.25K
10-Q · filed 2019-05-14
$975.97K
derived: sum of 2 quarters · filed 2020-05-14
$1.43M
derived: sum of 3 quarters · filed 2020-05-14
$1.91M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$529.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$979.29K
derived: sum of 2 quarters · filed 2020-03-13
$1.47M
derived: sum of 3 quarters · filed 2020-03-13
$1.84M
10-K · filed 2020-03-13
2018-09-30$449.67K
10-Q · filed 2019-11-12
$936.65K
derived: sum of 2 quarters · filed 2019-11-12
$1.31M
10-Q · filed 2019-11-12
$1.67M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$486.98K
10-Q · filed 2019-08-08
$859.34K
10-Q · filed 2019-08-08
$1.22M
derived: sum of 3 quarters · filed 2019-08-08
$1.55M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$372.36K
10-Q · filed 2019-05-14
$729.23K
derived: sum of 2 quarters · filed 2019-05-14
$1.06M
derived: sum of 3 quarters · filed 2019-05-14
$1.77M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$356.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$686.22K
derived: sum of 2 quarters · filed 2019-03-12
$1.39M
derived: sum of 3 quarters · filed 2019-03-12
$1.75M
10-K · filed 2019-03-12
2017-09-30$329.36K
10-Q · filed 2018-11-07
$1.04M
derived: sum of 2 quarters · filed 2018-11-07
$1.39M
10-Q · filed 2018-11-07
$1.80M
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$708.62K
10-Q · filed 2018-08-08
$1.07M
10-Q · filed 2018-08-08
$1.47M
derived: sum of 3 quarters · filed 2018-08-08
$1.71M
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$356.88K
10-Q · filed 2018-05-10
$763.50K
derived: sum of 2 quarters · filed 2018-05-10
$1.00M
derived: sum of 3 quarters · filed 2018-05-10
$1.26M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$406.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$644.31K
derived: sum of 2 quarters · filed 2018-03-12
$902.59K
derived: sum of 3 quarters · filed 2018-03-12
$1.12M
10-K · filed 2018-03-12
2016-09-30$237.69K
10-Q · filed 2017-11-08
$495.97K
derived: sum of 2 quarters · filed 2017-11-08
$714.33K
10-Q · filed 2017-11-08
2016-06-30$258.28K
10-Q · filed 2017-08-14
$471.37K
10-Q · filed 2017-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B